Skip to main content
logo
Genmab A/S (LON:0MGB)
London flag London · Delayed Price · Currency is GBP · Price in DKK
1,857.70
+12.22 (0.66%)
At close: Oct 31, 2025

Genmab Revenue

Genmab had revenue of $925.00M USD in the quarter ending June 30, 2025, with 18.74% growth. This brings the company's revenue in the last twelve months to $3.65B, up 32.97% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
$3.65B
Revenue Growth
+32.97%
P/S Ratio
5.06
Revenue / Employee
$1.36M
Employees
2,682
Market Cap
13.48B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.134.89B
Unilever51.24B
HSBC Holdings43.13B
AstraZeneca41.24B
Rio Tinto Group39.22B
GSK plc32.17B
British American Tobacco p.l.c.25.60B
Revenue Rankings

Genmab News

More News